FDA Panel Pans HIFU for Prostate CancerFDA Panel Pans HIFU for Prostate Cancer
An FDA advisory committee recommended against approval of high-intensity focused ultrasound (HIFU) for prostate cancer because of 'murkiness' of data. Medscape Medical News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | High Intensity Focused Ultrasound Therapy | Prostate Cancer | Radiology | Ultrasound